ESSA Pharma to Present at the JonesHealthcare Seaside Summit
ESSA Pharma to Present at the JonesHealthcare Seaside Summit
SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, July 8, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will present at the JonesHealthcare Seaside Summit on Monday, July 15, 2024 at 11:00 a.m. PT.
2024年7月8日，加利福尼亞州南舊金山和不列顛哥倫比亞省溫哥華 /美通社/ --ESSA Pharma Inc.（以下簡稱公司）（納斯達克：EPIX），一家臨床階段的藥物公司，專注於開發治療前列腺癌的新型療法，今天宣佈，公司將於2024年7月15日星期一上午11:00太平洋時間在JonesHealthcare Seaside Summit上進行演講。
David R. Parkinson, President and Chief Executive Officer, will host the presentation and will also participate in a panel discussion titled "Innovations and Challenges in Prostate Cancer" at 9:00 a.m. PT.
演講將由總裁兼首席執行官David R. Parkinson主持，並將在太平洋時間上午9:00參加標題爲“前列腺癌創新與挑戰”的小組討論。
A live webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at . Following the event, the webcast will be archived on the ESSA website for 90 days. The panel, "Innovations and Challenges in Prostate Cancer," will not be webcast.
演示的現場網絡廣播可以在ESSA網站的投資者/事件和演示文稿部分訪問。活動結束後，網絡廣播將在ESSA網站上存檔90天。小組“前列腺癌的創新與挑戰”不會進行網絡廣播。
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit , and follow us on X and LinkedIn.
關於ESSA Pharma Inc。
ESSA是一家臨床階段的製藥公司，專注於開發治療前列腺癌患者的新型專有療法。有關更多信息，請訪問網站，並在X和領英上關注我們。
Contacts
ESSA Pharma Inc.
Peter Virsik, Chief Operating Officer
778.331.0962
[email protected]
聯繫方式
ESSA Pharma Inc。
彼得·維爾希克（Peter Virsik），首席運營官
778.331.0962
[email protected]
Investors and Media:
Argot Partners
212.600.1902
[email protected]
投資者和媒體:
阿哥特合夥人。
212.600.1902
[email protected]
SOURCE ESSA Pharma Inc
來源：ESSA Pharma Inc